We are live on
!
Find out more
RA
Ramius Advisors Portfolio holdings
AUM
$95.2M
1-Year Est. Return
7.33%
This Fund
S&P 500
This Quarter
Est. Return
-7.46%
1 Year Est. Return
+7.33%
3 Year Est. Return
+186.73%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$395M
AUM Growth
+$163M
(+70%)
Cap. Flow
+$280M
Cap. Flow
% of AUM
71%
Top 10 Holdings %
Top 10 Hldgs %
67.83%
Holding
102
New
40
Increased
17
Reduced
4
Closed
41
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KEM
KEMET Corporation
KEM
|
+$33.6M |
| 2 |
TIF
Tiffany & Co.
TIF
|
+$27M |
| 3 |
TCO
Taubman Centers Inc.
TCO
|
+$24.8M |
| 4 |
CY
Cypress Semiconductor
CY
|
+$23.6M |
| 5 |
AXE
Anixter International Inc
AXE
|
+$23.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MDCO
Medicines Co
MDCO
|
+$35.7M |
| 2 |
ZAYO
Zayo Group Holdings, Inc.
ZAYO
|
+$19.8M |
| 3 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
+$13.2M |
| 4 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$11.9M |
| 5 |
WMGI
Wright Medical Group Inc
WMGI
|
+$7.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.19% |
| 2 | Healthcare | 17% |
| 3 | Consumer Discretionary | 12.6% |
| 4 | Industrials | 10.7% |
| 5 | Financials | 10.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MEET
26
DELISTED
The Meet Group, Inc. Common Stock
MEET
| $3.81M | 0.96% |
+648,366
| New | +$3.69M |
|
|
BMY.RT
27
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $3.76M | 0.95% |
989,152
+214,961
| +28% | +$708K |
|
|
FSCT
28
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
| $3.1M | 0.79% |
+98,217
| New | +$3.07M |
|
|
RESI
29
DELISTED
Front Yard Residential Corporation Common Stock
RESI
| $2.95M | 0.75% |
246,653
+149,562
| +154% | +$1.75M |
|
30
XPO
XPO
$24.7B
| $2.76M | 0.7% |
+163,933
| New | +$4.38M |
|
31
HP
HPQ
$22.1B
| $2.67M | 0.68% |
+153,696
| New | +$3.11M |
|
32
Adeia
ADEA
$2.89B
| $2.25M | 0.57% |
+610,591
| New | +$2.6M |
|
|
WBC
33
DELISTED
WABCO HOLDINGS INC.
WBC
| $2.11M | 0.53% |
15,599
-41,015
| -72% | -$5.52M |
|
34
CALL
RTX Corp
RTX
$262B
| $1.98M | 0.5% |
+291,105
| New | +$24.6M |
|
35
Stellantis
STLA
$16.7B
| $1.83M | 0.46% |
254,878
+170,480
| +202% | +$2.02M |
|
36
DuPont de Nemours
DD
$18.3B
| $1.66M | 0.42% |
+38,859
| New | +$2.38M |
|
|
ALLK
37
DELISTED
Allakos
ALLK
| $1.39M | 0.35% |
31,155
+813
| +3% | +$55.6K |
|
38
Occidental Petroleum
OXY
$54.9B
| $1.34M | 0.34% |
+115,397
| New | +$3.79M |
|
|
CBB
39
DELISTED
Cincinnati Bell Inc.
CBB
| $1.27M | 0.32% |
+87,063
| New | +$1.13M |
|
40
Axalta
AXTA
$6.87B
| $1.17M | 0.3% |
+67,846
| New | +$1.74M |
|
41
Morgan Stanley
MS
$332B
| $1.08M | 0.27% |
+31,756
| New | +$1.5M |
|
42
Pfizer
PFE
$141B
| $1.06M | 0.27% |
+34,196
| New | +$1.17M |
|
43
Viatris
VTRS
$19.8B
| $1.04M | 0.26% |
+70,000
| New | +$1.34M |
|
44
Genworth Financial
GNW
$3.87B
| $1.03M | 0.26% |
308,897
+87,722
| +40% | +$364K |
|
45
Xerox
XRX
$341M
| $1.01M | 0.25% |
+53,126
| New | +$1.69M |
|
|
ETFC
46
DELISTED
E*Trade Financial Corporation
ETFC
| $686K | 0.17% |
+20,000
| New | +$845K |
|
|
47
CALL
Pfizer
PFE
$141B
| $611K | 0.15% |
+421,600
| New | +$14.4M |
|
|
BREW
48
PUT
DELISTED
Craft Brew Alliance, Inc.
BREW
| $562K | 0.14% |
295,800
+182,400
| +161% | +$2.86M |
|
|
OMN
49
DELISTED
OMNOVA Solutions Inc.
OMN
| $525K | 0.13% |
+51,751
| New | +$516K |
|
|
MLNX
50
PUT
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $339K | 0.09% |
95,600
-68,000
| -42% | -$8M |
|
Similar funds
ACM
CWM
HLCM
ETM
CFA
ACM
UPC
AMC
Ramius Advisors's Q1 2020 Portfolio in Review
As of Q1 2020, Ramius Advisors held 102 positions worth $395M, up 70% from $233M the previous quarter. Its ten largest holdings account for 68% of the portfolio.
Ramius Advisors deployed $280M of net new capital in Q1 2020, opening 40 new positions and adding to 17 existing holdings. Its largest new stake was Taubman Centers Inc.: 594,441 shares worth $24.9M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was WABCO HOLDINGS INC., an estimated $5.52M trimmed.
- Ramius Advisors's largest Q1 2020 buy was Taubman Centers Inc.: 594,441 shares worth $24.9M.
- Ramius Advisors added most to KEMET Corporation in Q1 2020, an estimated $33.6M increase.
- Ramius Advisors's biggest Q1 2020 reduction was WABCO HOLDINGS INC., cutting an estimated $5.52M.
- Ramius Advisors fully exited Medicines Co in Q1 2020, selling an estimated $35.7M.
- Ramius Advisors's ten largest holdings make up 68% of its $395M portfolio in Q1 2020.
- Ramius Advisors opened 40 new positions and closed 41 in Q1 2020.
- Ramius Advisors's portfolio value rose 70% quarter-over-quarter to $395M.
Based on Ramius Advisors's 13F filing for Q1 2020, filed 14 May 2020.